Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial

Pierre Theroux Paul W Armstrong; Lina M Gonzales; Kenneth W Mahaffey; Judith S Hochman; Scott Rollins; Kevin J Malloy; Thomas Parish; José Carlos Nicolau; Joel Lavoie; Christopher B Granger; Annual Scientific Session American College of Cardiology (53. 2004 New Orleans, EUA)

Journal American College of Cardiology New York v.43, suppl. A, p. 287A, res. 833-5, 2004

New York 2004

Disponible en FM - Fac. Medicina    (BCSEP 2004 65 ) y otras localizaciones(Obténgalo)